1. Home
  2. ZLAB vs STC Comparison

ZLAB vs STC Comparison

Compare ZLAB & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • STC
  • Stock Information
  • Founded
  • ZLAB 2013
  • STC 1893
  • Country
  • ZLAB China
  • STC United States
  • Employees
  • ZLAB N/A
  • STC N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • STC Specialty Insurers
  • Sector
  • ZLAB Health Care
  • STC Finance
  • Exchange
  • ZLAB Nasdaq
  • STC Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • STC 2.0B
  • IPO Year
  • ZLAB 2017
  • STC N/A
  • Fundamental
  • Price
  • ZLAB $35.00
  • STC $65.30
  • Analyst Decision
  • ZLAB Buy
  • STC Buy
  • Analyst Count
  • ZLAB 5
  • STC 3
  • Target Price
  • ZLAB $54.28
  • STC $77.67
  • AVG Volume (30 Days)
  • ZLAB 1.0M
  • STC 175.1K
  • Earning Date
  • ZLAB 08-05-2025
  • STC 07-23-2025
  • Dividend Yield
  • ZLAB N/A
  • STC 3.07%
  • EPS Growth
  • ZLAB N/A
  • STC 72.76
  • EPS
  • ZLAB N/A
  • STC 2.60
  • Revenue
  • ZLAB $418,326,000.00
  • STC $2,547,588,000.00
  • Revenue This Year
  • ZLAB $44.07
  • STC $11.17
  • Revenue Next Year
  • ZLAB $49.13
  • STC $11.31
  • P/E Ratio
  • ZLAB N/A
  • STC $25.06
  • Revenue Growth
  • ZLAB 43.72
  • STC 11.27
  • 52 Week Low
  • ZLAB $16.01
  • STC $58.61
  • 52 Week High
  • ZLAB $44.34
  • STC $78.44
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 51.28
  • STC 55.26
  • Support Level
  • ZLAB $34.44
  • STC $60.08
  • Resistance Level
  • ZLAB $38.18
  • STC $66.07
  • Average True Range (ATR)
  • ZLAB 1.33
  • STC 1.56
  • MACD
  • ZLAB -0.44
  • STC 0.50
  • Stochastic Oscillator
  • ZLAB 17.66
  • STC 73.37

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

Share on Social Networks: